Literature DB >> 18786974

Body mass does not have a clinically relevant effect on cystatin C eGFR in children.

Ajay P Sharma1, Anusha Kathiravelu, Renisha Nadarajah, Abeer Yasin, Guido Filler.   

Abstract

BACKGROUND: Unlike creatinine, Cystatin C (CysC) is believed to be independent of body composition in both adults and children. Recent findings in adults, suggesting an improved performance of CysC-based estimated glomerular filtration rate (CysC eGFR) by accounting for body mass, necessitated a careful re-evaluation of this issue in children.
METHODS: We studied 240 children (median age 11.7 years, range 2-17.9 years, 107 girls), with various kidney diseases, for any change in the relationship between (99)Tc DTPA GFR and CysC eGFR after accounting for body mass. For body mass assessment, body mass index (BMI) z-score was calculated using height-adjusted age, to account for growth retardation secondary to chronic kidney disease.
RESULTS: CysC eGFR did not have a significant correlation with BMI z-score (correlation coefficient = 0.06; P = 0.34). Accounting for BMI z-score did not add to the 65% variance in nuclear GFR explained by CysC eGFR. Moreover, it did not change the regression coefficient of 0.85 between CysC eGFR and nuclear GFR either. On Bland & Altman analysis, the bias of 0.05 and standard deviation of 20.39 also did not improve after accounting for BMI z-score in the revised CysC eGFR formula.
CONCLUSIONS: In children, body mass exerts a minimal effect on the performance of CysC eGFR estimation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786974     DOI: 10.1093/ndt/gfn505

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  A step forward towards accurately assessing glomerular filtration rate in newborns.

Authors:  Guido Filler
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

2.  Cystatin C adaptation in the first month of life.

Authors:  Guido Filler; Nathalie Lepage
Journal:  Pediatr Nephrol       Date:  2013-02-23       Impact factor: 3.714

Review 3.  Methods of assessing renal function.

Authors:  Guido Filler; Abeer Yasin; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2013-02-17       Impact factor: 3.714

4.  Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis.

Authors:  Shih-Han S Huang; Guido Filler; Abeer Yasin; Robert M Lindsay
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

5.  Cystatin C, cardiometabolic risk, and body composition in severely obese children.

Authors:  Pilar Codoñer-Franch; Esther Ballester-Asensio; Lorena Martínez-Pons; Jorge Vallecillo-Hernández; Almudena Navarro-Ruíz; Ramón del Valle-Pérez
Journal:  Pediatr Nephrol       Date:  2010-11-19       Impact factor: 3.714

6.  Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula.

Authors:  Christopher I Esezobor; Edna Iroha; Olajumoke Oladipo; Elizabeth Onifade; Oyetunji O Soriyan; Adebola O Akinsulie; Edamisan O Temiye; Chinyere Ezeaka
Journal:  J Int AIDS Soc       Date:  2010-05-18       Impact factor: 5.396

7.  Serum cystatin C predicts acute kidney injury in preterm neonates with respiratory distress syndrome.

Authors:  Ahmet Taner Elmas; Yilmaz Tabel; Ozlem Nalbantoğlu Elmas
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

8.  Development of a beta-trace protein based formula for estimation of glomerular filtration rate.

Authors:  Amina Benlamri; Renisha Nadarajah; Abeer Yasin; Nathalie Lepage; Ajay P Sharma; Guido Filler
Journal:  Pediatr Nephrol       Date:  2009-12-01       Impact factor: 3.714

9.  Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities.

Authors:  Najila Al-Malki; Paul A Heidenheim; Guido Filler; Abeer Yasin; Robert M Lindsay
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

10.  Cystatin C in children on chronic hemodialysis.

Authors:  Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.